Avenue Therapeutics, Inc. (ATXI)
OTCMKTS
· Delayed Price · Currency is USD
0.3000
0.00 (0.00%)
Mar 31, 2025, 12:03 PM EST
Avenue Therapeutics Employees
Avenue Therapeutics had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$6,092,667
Market Cap
594.50K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Avenue Therapeutics News
- 4 months ago - Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 months ago - Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - GlobeNewsWire
- 7 months ago - Avenue Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 10 months ago - Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 11 months ago - Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) - GlobeNewsWire
- 11 months ago - Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds - GlobeNewsWire